NCT01868490View on ClinicalTrials.gov

The Adoptive Immunotherapy for Solid Tumors Using Modified Autologous CIK Cells

PHASE1/PHASE2Enrolling by invitationINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

April 17, 2009

Primary Completion Date

January 30, 2028

Study Completion Date

May 30, 2028

Conditions
CholangiocarcinomaNeuroblastoma
Interventions
DRUG

cytokine induced killer cells

at least 10\*9 CIK cells, IV on day 0, 14, 28

Trial Locations (2)

10700

Siriraj Clinical Research Center, Siriraj Hospital, Bangkoknoi

Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok

All Listed Sponsors
collaborator

Mahidol University

OTHER

lead

Siriraj Hospital

OTHER

NCT01868490 - The Adoptive Immunotherapy for Solid Tumors Using Modified Autologous CIK Cells | Biotech Hunter | Biotech Hunter